The Team



Robert M. Blinstrub is Chief Executive Officer of XG Sciences, a position he assumed in August 2020. Blinstrub has been an investor in XGS since 2018 and has served as a Member of the Board of Directors since March 2019. Blinstrub was founder, President and CEO of Applied Global Manufacturing, Inc. (“AGM”), a company he started in 2000. Headquartered in Troy, Michigan, AGM was a designer, innovator, and producer of engineered solutions for automobiles, with 9 production facilities around the world, including Austria, China, Costa Rica and Mexico. Under Blinstrub’s 17 years of leadership, AGM doubled its revenue every 18 months on average and had total revenue of approximately $500 million and 2,000 employees when it was acquired by Flex, Ltd. (NASDAQ: FLEX) in April 2017. During his tenure, AGM accumulated supplier awards for world class quality, product design, engineering, innovation, and service. Prior to AGM, Blinstrub led multiple startups and operational turnarounds.



Jackie Lemke is the chief financial officer of XG Sciences, Inc. Lemke has served on the Board of Directors of the American Brain Tumor Association since January of 2017. From 2012 to 2016, she served as president and CEO of Bioanalytical Systems, Inc., a NASDAQ-listed contract biopharmaceutical research organization. At Bioanalytical Systems, Lemke successfully refinanced and modernized the company’s capabilities while positioning the business for sustainable value creation. From 2007 to 2010, she served as vice president of finance and global CFO of Remy, Inc., a billion-dollar division of Remy International. From 2004 to 2005, she served as vice president of finance and global CFO of Connected Home Solutions at Motorola, Inc. Prior to that, Lemke was global strategic planning director of the multi-billion dollar revenue Invista division at the DuPont Company. She began her career as a tax consultant at Deloitte & Touche and is a Certified Public Accountant (CPA). Jackie earned her bachelor’s degree in finance and accounting from Drexel University and her master’s degree in management from Northwestern University.



Andrew J. (AJ) Boechler is Chief Commercial Officer of XG Sciences. He joined XGS in 2020 following a successful 30-year career with General Electric Company, where he provided executive leadership in a variety of industries and markets including Plastics, Healthcare, Automotive, Oil and Gas, Power Generation, Consumer Electronics, Automation and Industrial Inspection Technologies. While at GE, Boechler built global organizations and brands, developing solutions in both start-up and established business environments.



Leroy Magwood, Jr. is the Chief Technology Officer at XG Sciences. Dr. Magwood joined XG Sciences, Inc. in 2019, bringing with him more than 10 years of research experience and consulting for product development in the areas of paints and coatings, electronics, pharmaceuticals and nuclear development. Prior to XG Sciences, Dr. Magwood lead research and development activities at DSM Functional Materials, PPG and Savannah River National Laboratory. Dr. Magwood was also a key contributor to the development of formulations and technologies that were instrumental to the establishment of Surmasis Pharmaceuticals as well as a 3D Printing company in San Francisco, California. Dr. Magwood is a graduate of the University of Iowa earning his Ph.D. in Chemical and Biochemical Engineering and Benedict College receiving his B.S. in Physics.



Mr. Murray has over 30 years of experience as a senior operations executive. As founder and CEO of Uretech International Inc., a manufacturer of specialty chemicals and urethane products for the automotive, medical and furniture industries, he directed all activities of the company. Mr. Murray held upper management positions at Motor Wheel Corporation and McKechnie Automotive. He earned his BS in Metallurgical Engineering from Michigan Tech University, and is a registered Professional Engineer; he also holds a Six Sigma Black Belt certification.



Dr. Fukushima is a founding share holder of the Company. Dr. Fukushima’s PhD research led to the development of xGnP® Graphene Nanoplatelets for composite and battery applications. His expertise was instrumental in designing xGnP® composites, which showed better properties than existing composite products. This research led to two filed patents and six applied patents. He earned his PhD in Materials Science from Michigan State University. Before earning his PhD, Dr. Fukushima received his BS and MS in Polymer Science from Osaka University in Japan. He brings additional project management experience with carbon fibers, carbon nanotubes, graphite oxides, and nanoclays to XG Sciences.



Dr. Lawrence T. Drzal, co-founder of XG Sciences, Inc., is a University Distinguished Professor of Chemical Engineering and Materials Science, and Director of the Composite Materials and Structures Center at Michigan State University. He earned his PhD at Case Western Reserve University, after serving as a military and civilian researcher at the U.S.A.F. Materials Laboratory at Wright-Patterson AFB. His research focuses on discovering the fundamental physical and chemical interactions that take place between polymers and the surfaces of materials in composite materials, nanocomposites, and adhesive bonds. Dr. Drzal’s current research explores the functionalization and dispersion of graphene nanoplatelets in polymers and composite materials, and their nano-structuring for composite multifunctionality and enhanced energy generation and storage applications. Professor Drzal has published more than 350 peer reviewed research papers, and has been awarded 31 patents.